Description

Egystrozol (Anastrozole) Coated Tablets 1 mg. №28

Ingredients:

Each coated tablet contains 1 mg of Anastrozole.

Dosage:

The recommended dosage is 1 tablet taken orally once a day.

Indications:

Egystrozol is indicated for the treatment of hormone receptor-positive early breast cancer in postmenopausal women.

Contraindications:

Do not use Egystrozol if you are pregnant, breastfeeding, or allergic to Anastrozole.

Directions:

Take Egystrozol exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage.

Scientific Evidence:

Anastrozole, the active ingredient in Egystrozol, is a potent and selective aromatase inhibitor. It works by reducing the production of estrogen in the body, which can slow down or stop the growth of hormone receptor-positive breast cancer cells. Clinical studies have shown that Anastrozole is effective in reducing the risk of cancer recurrence in postmenopausal women with early-stage breast cancer.

Research published in the New England Journal of Medicine has demonstrated the superior efficacy of Anastrozole compared to tamoxifen in the adjuvant treatment of early breast cancer. The study showed that Anastrozole significantly reduced the risk of cancer recurrence without some of the side effects associated with tamoxifen.

Additional Information:

• Storage: Store Egystrozol at room temperature away from moisture and heat.
• Side Effects: Common side effects may include hot flashes, joint pain, and fatigue.
• Precautions: Inform your doctor about any other medications you are taking before starting Egystrozol.